Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Tward

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Cancer Journal (Sudbury, Mass.)|February 7, 2009
Survival and recurrence in nonmycosis fungoides primary cutaneous lymphomaJonathan D Tward, Charles V Cachoeira, Mohammed E Salama, et al.
Practical Radiation Oncology|March 10, 2017
Comparison of 2 transabdominal ultrasound image guidance techniques for prostate and prostatic fossa radiation therapyBill J Salter, Martin Szegedi, Christine Boehm, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2010
American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapyBeth A Erickson, D Jeffrey Demanes, Geoffrey S Ibbott, et al.
Advances in Radiation Oncology|July 26, 2017
Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapyVictor J Gonzalez, Craig R Hullett, Lindsay Burt, et al.
Clinical Genitourinary Cancer|February 20, 2021
Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality TherapyJonathan D Tward, Thorsten Schlomm, Stephen Bardot, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2010
Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysisTamara Z Vern-Gross, Anand T Shivnani, Ke Chen, et al.
American Journal of Clinical Oncology|July 12, 2012
Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: a surveillance, epidemiology, and end results (SEER) analysisGuy Jones, Benjamin Arthurs, Hakan Kaya, et al.
Advances in Radiation Oncology|November 24, 2022
Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation TherapyCalvin B Rock, Jonathan J Chipman, Matthew W Parsons, et al.
Clinical Genitourinary Cancer|April 27, 2020
Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality RadiotherapyJonathan D Tward, Brock O'Neil, Ken Boucher, et al.
JCO Oncology Practice|September 18, 2023
Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative MedicineRyan J Hutten, Christopher R Weil, Andy J King, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Cancer Journal (Sudbury, Mass.)|February 7, 2009
Survival and recurrence in nonmycosis fungoides primary cutaneous lymphomaJonathan D Tward, Charles V Cachoeira, Mohammed E Salama, et al.
Practical Radiation Oncology|March 10, 2017
Comparison of 2 transabdominal ultrasound image guidance techniques for prostate and prostatic fossa radiation therapyBill J Salter, Martin Szegedi, Christine Boehm, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2010
American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapyBeth A Erickson, D Jeffrey Demanes, Geoffrey S Ibbott, et al.
Advances in Radiation Oncology|July 26, 2017
Impact of prone versus supine positioning on small bowel dose with pelvic intensity modulated radiation therapyVictor J Gonzalez, Craig R Hullett, Lindsay Burt, et al.
Clinical Genitourinary Cancer|February 20, 2021
Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality TherapyJonathan D Tward, Thorsten Schlomm, Stephen Bardot, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2010
Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysisTamara Z Vern-Gross, Anand T Shivnani, Ke Chen, et al.
American Journal of Clinical Oncology|July 12, 2012
Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: a surveillance, epidemiology, and end results (SEER) analysisGuy Jones, Benjamin Arthurs, Hakan Kaya, et al.
Advances in Radiation Oncology|November 24, 2022
Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation TherapyCalvin B Rock, Jonathan J Chipman, Matthew W Parsons, et al.
Clinical Genitourinary Cancer|April 27, 2020
Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality RadiotherapyJonathan D Tward, Brock O'Neil, Ken Boucher, et al.
JCO Oncology Practice|September 18, 2023
Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative MedicineRyan J Hutten, Christopher R Weil, Andy J King, et al.
Pageof 8